Jeffrey Edward Nelson Net Worth

What's Jeffrey Nelson's mailing address?

Jeffrey's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, A8, H4M 2X6.

Insiders trading at Milestone Pharmaceuticals Inc

Over the last 5 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic... et Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.

What does Milestone Pharmaceuticals Inc do?

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.

Milestone Pharmaceuticals Inc executives and stock owners

Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Joseph G. Oliveto,
  CEO, Pres & Director
• Amit Hasija,
  CFO & Exec. VP of Corp. Devel.
• Dr. Francis Plat,
  Chief Medical Officer
• Lorenz Muller,
  Chief Commercial Officer
• Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
  Chief Medical Advisor & Member of the Scientific Advisory Board
• Jeff Nelson,
  Chief Operating Officer
• Dr. Philippe Douville,
  Founder, Strategic Advisor & Member of Scientific Advisory Board
• Richard C Pasternak,
  Director
• Debra K. Liebert,
  Director
• Paul F Truex,
  Director
• Joseph C Papa,
  
• Amit Hasija,
  CFO & EVP of Corp. Development
• Seth H. Z. Fischer,
  
• Timothy Maness,
  Chief Accounting Officer
• Philippe Douville,
  Chief Scientific Officer
• De Solidarite Des Travaille...,
  10% owner
• Holdings A/S Novo,
  10% owner
• Investments, Lpwong Roderic...,
  
• Capital Inc. Bdc,
  10% owner
• Francis Plat,
  Chief Medical Officer
• Joseph Oliveto,
  President and CEO
• Lorenz Muller,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Michael John Tomsicek,
  
• Stuart Duty,
  
• David Bharucha,
  Chief Medical Officer
• Jeffrey Edward Nelson,
  Chief Operating Officer
• Lisa M. Giles,
  
• Robert James Wills,